Vectibix®
Sponsors
Qilu Pharmaceutical Co., Ltd., R-Pharm
Conditions
Healthy MalesMetastatic Colorectal Cancer
Phase 1
Comparing the Pharmacokinetic and Safety of QL1203 and Vectibix® in Healthy Males.
NCT04234594
Start: 2019-10-28End: 2020-09-30Target: 94Updated: 2020-05-19
A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI
RecruitingNCT07543744
Start: 2025-04-17End: 2028-08-01Target: 180Updated: 2026-04-22